FA
ABBV icon

FSA Advisors’s AbbVie ABBV Stock Holding History

FSA Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$559K Sell
2,569
-9,509
-79% -$2.11M 0.37% 83
2025
Q4 		$520K Buy
12,078
+9,972
+474% +$2.27M 0.36% 83
2025
Q3 		$488K Buy
2,106
+1,027
+95% +$209K 0.39% 77
2025
Q2 		$200K Sell
1,079
-14
-1% -$2.6K 0.16% 171
2025
Q1 		$229K Buy
+1,093
New +$212K 0.18% 157

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FSA Advisors's ABBV Position: Q1 2026 in Review

FSA Advisors reduced its AbbVie (ABBV) stake by 79% in Q1 2026, selling an estimated $2.11M and leaving 2,569 shares worth $559K. The position accounts for 0.37% of the portfolio, ranked #83.

FSA Advisors first reported a position in ABBV in Q1 2025 and has held it in 5 quarters since. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • FSA Advisors held 2,569 shares of AbbVie worth $559K as of Q1 2026.
  • FSA Advisors sold 9,509 AbbVie shares in Q1 2026, an estimated $2.11M.
  • AbbVie made up 0.37% of FSA Advisors's portfolio in Q1 2026, its #83 holding.
  • FSA Advisors first reported a position in AbbVie in Q1 2025 and has held it in 5 quarters since.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on FSA Advisors's 13F filing for Q1 2026, filed 6 May 2026.